Biocon Limited Pharmaceutical preparations NES,Bengaluru

Bengaluru 560100- India

Presentation - Biocon Limited

Biocon Limited is a global innovation-led biopharmaceutical company headquartered in Bengaluru, India, focused on developing affordable medicines for chronic diseases such as diabetes, cancer, and autoimmune disorders. The company operates across multiple segments including biosimilars, generic formulations, active pharmaceutical ingredients (APIs), and novel biologics, serving patients in more than 120 countries. Through advanced research, large-scale manufacturing, and strategic partnerships, Biocon aims to improve access to high-quality therapies while supporting healthcare systems and pharmaceutical partners worldwide.

Biosimilars
Biocon develops and manufactures biosimilar medicines that replicate complex biologic therapies used to treat conditions such as diabetes, oncology, and autoimmune diseases. These products help healthcare providers and pharmaceutical partners reduce treatment costs while maintaining high clinical effectiveness and regulatory compliance.

Generic Formulations
Biocon offers a broad portfolio of generic drug formulations addressing therapeutic areas including metabolics, oncology, immunology, and cardiovascular diseases. These cost-effective pharmaceutical solutions are manufactured to global quality standards and supplied to regulated and emerging markets worldwide.

Active Pharmaceutical Ingredients (APIs)
The company manufactures complex small-molecule APIs used by pharmaceutical companies in the production of finished drug formulations. Biocon’s API portfolio supports therapeutic segments such as cardiology, anti-diabetics, and immunosuppressants, providing reliable supply and regulatory-compliant manufacturing.

Branded Formulations
Biocon develops branded pharmaceutical products primarily for the Indian market across chronic therapy areas like diabetes, oncology, nephrology, and immunology. These medicines combine established molecules with strong clinical efficacy to deliver accessible treatment options for patients and healthcare providers.

Novel Biologics Research
Biocon invests in research and development of novel biologic therapies designed to address unmet medical needs in complex diseases. This segment focuses on innovation in biotechnology platforms, supporting the discovery and development of next-generation therapeutic proteins and monoclonal antibodies.

Executives - Biocon Limited Buy the executives list from same sector

Mr Atul Dhawan

Director (Additional Director)

Spoken languages  en

Location -  Biocon Limited

20th KM, - Hosur Road, Electronic City, - Bengaluru 560100 - India

Follow us - Biocon Limited

Kompass membership

Kompass ID? IN723587

Legal information - Biocon Limited

Type Headquarters
Year established 1978
Legal form Limited Company
Activity
Corporate capital 0 INR
Registration No. 3417
VAT no 29AAACB7461R2ZY
No employees (address) Not declared 
No employees More than 5000 Employees

General Information -  Biocon Limited

Associations

FICCI

Pharmaceuticals Export Promotion Council

Banks

State Bank of India

Import area
Worldwide
Export area
Worldwide
Certifications
Type: ISO 9001 2000

Other Companies recommended by Kompass:

Looking for new B2B Leads ?

Purchase a Company list with the executives and contact details

  • Verified decision-maker contacts
  • Accurate B2B targeting by sector
  • Immediate Excel/CSV export